A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Boston Scientific Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 218,756 shares of BSX stock, worth $19.9 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
218,756
Previous 23,295 839.07%
Holding current value
$19.9 Million
Previous $1.79 Million 922.36%
% of portfolio
0.1%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$72.96 - $84.0 $14.3 Million - $16.4 Million
195,461 Added 839.07%
218,756 $18.3 Million
Q2 2024

Aug 09, 2024

BUY
$67.33 - $77.71 $785,337 - $906,409
11,664 Added 100.28%
23,295 $1.79 Million
Q1 2024

May 09, 2024

SELL
$57.6 - $68.62 $4.22 Million - $5.03 Million
-73,281 Reduced 86.3%
11,631 $796,000
Q4 2023

Feb 09, 2024

BUY
$48.64 - $57.81 $4.13 Million - $4.91 Million
84,912 New
84,912 $4.91 Million
Q3 2022

Nov 10, 2022

SELL
$36.71 - $109.66 $101,723 - $303,867
-2,771 Reduced 1.65%
165,073 $6.39 Million
Q2 2022

Aug 05, 2022

SELL
$35.24 - $47.1 $4.45 Million - $5.94 Million
-126,207 Reduced 42.92%
167,844 $6.26 Million
Q1 2022

May 12, 2022

BUY
$40.9 - $45.1 $12 Million - $13.3 Million
294,051 New
294,051 $13 Million
Q3 2021

Nov 12, 2021

SELL
$41.23 - $45.88 $3.91 Million - $4.35 Million
-94,751 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$38.58 - $44.24 $5.11 Million - $5.86 Million
-132,553 Reduced 58.32%
94,751 $4.05 Million
Q1 2021

May 13, 2021

BUY
$35.27 - $39.67 $8.02 Million - $9.02 Million
227,304 New
227,304 $8.79 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $6.3 Million - $7.98 Million
-190,152 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$34.44 - $42.23 $5.4 Million - $6.62 Million
156,839 Added 470.8%
190,152 $7.27 Million
Q4 2019

Feb 12, 2020

BUY
$37.87 - $45.37 $1.26 Million - $1.51 Million
33,313 New
33,313 $1.51 Million
Q2 2019

Aug 07, 2019

SELL
$34.91 - $42.98 $272,751 - $335,802
-7,813 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$32.91 - $40.75 $257,125 - $318,379
7,813 New
7,813 $300,000
Q1 2018

May 14, 2018

SELL
$25.2 - $28.54 $6.94 Million - $7.86 Million
-275,339 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$24.79 - $29.8 $4.88 Million - $5.86 Million
-196,775 Reduced 41.68%
275,339 $6.83 Million
Q3 2017

Nov 14, 2017

SELL
$26.26 - $29.17 $10 Million - $11.1 Million
-380,900 Reduced 44.65%
472,114 $13.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
853,014
853,014 $23.6 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.